Cargando…

Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease

Huntington’s disease (HD) is a movement disorder caused by a mutation in the Huntingtin gene that leads to severe neurodegeneration. Molecular mechanisms of HD are not sufficiently understood, and no cure is currently available. Here, we demonstrate neuroprotective effects of hepatoma-derived growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voelkl, Kerstin, Gutiérrez-Ángel, Sara, Keeling, Sophie, Koyuncu, Seda, da Silva Padilha, Miguel, Feigenbutz, Dennis, Arzberger, Thomas, Vilchez, David, Klein, Rüdiger, Dudanova, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427761/ https://www.ncbi.nlm.nih.gov/pubmed/37580082 http://dx.doi.org/10.26508/lsa.202302018

Ejemplares similares

Distinct histological alterations of cortical interneuron types in mouse models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2022)

Cortical circuit alterations precede motor impairments in Huntington’s disease mice
por: Burgold, Johanna, et al.
Publicado: (2019)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
por: Hosp, Fabian, et al.
Publicado: (2017)

Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
por: Riera-Tur, Irene, et al.
Publicado: (2021)

G3BP1-dependent mechanism suppressing protein aggregation in Huntington’s models and its demise upon stress granule assembly
por: Gutiérrez-Garcia, Ricardo, et al.
Publicado: (2023)

The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients
por: Koyuncu, Seda, et al.
Publicado: (2018)

Author Correction: The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients
por: Koyuncu, Seda, et al.
Publicado: (2020)

Fluc‐EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease
por: Blumenstock, Sonja, et al.
Publicado: (2021)

Proteostasis of Huntingtin in Health and Disease
por: Koyuncu, Seda, et al.
Publicado: (2017)

Insights into the ubiquitin-proteasome system of human embryonic stem cells
por: Saez, Isabel, et al.
Publicado: (2018)

Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010)

Insights Into the Links Between Proteostasis and Aging From C. elegans
por: Zhang, William Hongyu, et al.
Publicado: (2022)

The composition of EphB2 clusters determines the strength in the cellular repulsion response
por: Schaupp, Andreas, et al.
Publicado: (2014)

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
por: Lauterbach, Edward C.
Publicado: (2013)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Pridopidine activates neuroprotective pathways impaired in Huntington Disease
por: Geva, Michal, et al.
Publicado: (2016)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Biosensors for Studying Neuronal Proteostasis
por: Dudanova, Irina
Publicado: (2022)

PINK1-induced mitophagy promotes neuroprotection in Huntington's disease
por: Khalil, B, et al.
Publicado: (2015)

Rewiring of the ubiquitinated proteome determines ageing in C. elegans
por: Koyuncu, Seda, et al.
Publicado: (2021)

Cold temperature extends longevity and prevents disease-related protein aggregation through PA28γ-induced proteasomes
por: Lee, Hyun Ju, et al.
Publicado: (2023)

Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations
por: Fatima, Azra, et al.
Publicado: (2019)

Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)

Multi-OMIC analysis of Huntington disease reveals a neuroprotective astrocyte state
por: Paryani, Fahad, et al.
Publicado: (2023)

PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2015)

Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
por: Pruccoli, Letizia, et al.
Publicado: (2021)

Prostaglandin signals from adult germline stem cells delay somatic aging of Caenorhabditis elegans
por: Lee, Hyun Ju, et al.
Publicado: (2019)

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
por: Boussicault, Lydie, et al.
Publicado: (2016)

Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington’s disease
por: Aron, Rebecca, et al.
Publicado: (2018)

Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease
por: Cattaneo, Monica, et al.
Publicado: (2022)

Somatic increase of CCT8 mimics proteostasis of human pluripotent stem cells and extends C. elegans lifespan
por: Noormohammadi, Alireza, et al.
Publicado: (2016)

In situ architecture of neuronal α-Synuclein inclusions
por: Trinkaus, Victoria A., et al.
Publicado: (2021)

Tropical Cirrhosis and Hepatoma
por: Coady, Anthony
Publicado: (1976)

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies
por: Brito, V, et al.
Publicado: (2013)

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease
por: Doria, JG, et al.
Publicado: (2013)

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s Disease
por: Chopra, Vanita, et al.
Publicado: (2016)

Molecular Strategies to Target Protein Aggregation in Huntington’s Disease
por: Jarosińska, Olga D., et al.
Publicado: (2021)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of Ca(V)1 Channels
por: Miranda, Artur S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6r3c2cbbacse6e6eqpbqedv1j0